These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Some results of the treatment of depressive states by a monoamine oxidase-inhibiting hydrazide, nialamide]. FOURNY L; SEGAL J; SEGAL A Toulouse Med; 1961 Feb; 62():137-41. PubMed ID: 13701049 [No Abstract] [Full Text] [Related]
4. [On the use of psychopharmacological agents with monoamino oxidase inhibitory effect in institutional psychiatry]. GROSS H Wien Med Wochenschr; 1960 Sep; 110():733-4. PubMed ID: 13709016 [No Abstract] [Full Text] [Related]
5. Efficacy of antidepressants. O'REILLY PO; HUGHES MJ Can Med Assoc J; 1961 Apr; 84(16):887-8. PubMed ID: 13730109 [No Abstract] [Full Text] [Related]
6. Psychic energizers in the depressed patient. SENSEMAN LA R I Med J; 1961 Apr; 44():217-9. PubMed ID: 13750119 [No Abstract] [Full Text] [Related]
7. [Use of a monoamine oxidase inhibiting hydrazide, isocarboxazide for the treatment of mental depression]. RISER M; GAYRAL L; HURON R; TURNIN J; CARRIE J Toulouse Med; 1960 Oct; 61():707-13. PubMed ID: 13741834 [No Abstract] [Full Text] [Related]
8. A preliminary report on MAO inhibition and clincial effectiveness in the treatment of depressed patients with phenelzine. FELDSTEIN A; HOAGLAND H; RIVIERA MR; FREEMAN H J Neuropsychiatr; 1960; 2():12-4. PubMed ID: 13698729 [No Abstract] [Full Text] [Related]
9. A report on the effects of phenelzine (nardil), a monoamine oxidase inhibitor, in depressed patients. MIDDLEFELL R; FROST I; EGAN GP; EATON H J Ment Sci; 1960 Oct; 106():1533-8. PubMed ID: 13770370 [No Abstract] [Full Text] [Related]
10. Indications, contraindications and treatment with monoamine oxidase inhibiting antidepressant drugs. SAINZ A Angiology; 1960 Feb; 11():94-8. PubMed ID: 14440834 [No Abstract] [Full Text] [Related]
11. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700. BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859 [No Abstract] [Full Text] [Related]
12. [Experiences in the treatment of depressive states with 1-seryl-2-isopropylhydrazine]. HEINRICH K Psychiatr Neurol (Basel); 1960 Jul; 140():119-25. PubMed ID: 13712966 [No Abstract] [Full Text] [Related]
13. Treatment of depressive states with marplan. OLTMAN JE; FRIEDMAN S Am J Psychiatry; 1960 Mar; 116():848-9. PubMed ID: 14428837 [No Abstract] [Full Text] [Related]
14. Chemical treatment of depression. AYD FJ Ann N Y Acad Sci; 1959 Sep; 80():734-44. PubMed ID: 13795342 [No Abstract] [Full Text] [Related]
15. The use of JB-516 in psychiatry. AGIN HV Ann N Y Acad Sci; 1959 Sep; 80():705-11. PubMed ID: 13792015 [No Abstract] [Full Text] [Related]
16. Experience with JB-516 and other psychochemicals. POMERANZE J Ann N Y Acad Sci; 1959 Sep; 80():835-42. PubMed ID: 14433949 [No Abstract] [Full Text] [Related]
17. Clinical evaluation of psychostimulants. TOBIN JM; PLANTE MA; KUPSKI L Ann N Y Acad Sci; 1959 Sep; 80():760-71. PubMed ID: 13838589 [No Abstract] [Full Text] [Related]
19. [Clinical experience with a new drug of the antidepressive series: phenelzine]. TORRIGIANI G Clin Ter; 1959 Oct; 17():382-7. PubMed ID: 13838955 [No Abstract] [Full Text] [Related]
20. [Study of the action of the isopropylhydrazide of p-chlorophenoxyacetic acid (P.C. 603), a new monoamine oxidase inhibitor, in depressive states]. BORENSTEIN P; DABBAH M; KRAMARZ P; HENON C Ann Med Psychol (Paris); 1961 Oct; 119(2)():554-65. PubMed ID: 13871268 [No Abstract] [Full Text] [Related] [Next] [New Search]